Biotech sector highly critical of Commission's patent stand, new survey reports
Marks & Clerk has released the findings of its most recent annual survey of executives working in the biotechnology industry. Among the highlights are:
• 72% of biotech executives fear the Commission’s enquiry into the pharmaceutical sector will…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.